AKT1 and lung adenocarcinoma: In conclusion, our study demonstrates that β-elemene effectively reverses cisplatin resistance in lung adenocarcinoma by downregulating the long non-coding RNA LINC00511, thereby suppressing the PI3K/AKT/mTOR signaling pathway.